Amenorrhea
Key Points
- Amenorrhea is absence of menstruation in reproductive-age clients with ovaries and uterus.
- Primary amenorrhea refers to absence of menarche by about age 16; secondary amenorrhea is absence of menses for at least three consecutive cycles after prior regular cycles.
- Pregnancy is the first condition to exclude in secondary amenorrhea evaluation.
- Etiologies include endocrine, hypothalamic-pituitary-ovarian, tumor, congenital, nutritional, and lifestyle contributors.
- Chronic hypoestrogenic states can increase bone-loss risk and require long-term surveillance and prevention planning.
Pathophysiology
Amenorrhea reflects disruption of the hypothalamic-pituitary-ovarian axis, target-organ anatomy, or systemic endocrine regulation. In primary amenorrhea, congenital or chromosomal causes are more common in the initial workup. In secondary amenorrhea, pregnancy, anovulation, weight/nutrition changes, pituitary-ovarian pathology, and hormonal disorders are frequent contributors.
When estrogen deficiency is prolonged, end-organ effects may include reduced bone mineral density and higher long-term fracture risk. Therefore, treatment planning must address both menstrual restoration and prevention of chronic complications.
Classification
- Primary amenorrhea: No menarche by about age 16.
- Secondary amenorrhea: No menstruation for three or more consecutive cycles after previously regular menses.
- Endocrine/hormonal causes: Hyperprolactinemia, thyroid dysfunction, Cushing-spectrum disorders, and related hormonal imbalance states.
- Structural/anatomic causes: Congenital anatomic variations (for example absent or obstructed reproductive structures).
- Lifestyle and functional causes: Significant weight loss, undernutrition, excessive exercise, and stress-related hypothalamic suppression.
Nursing Assessment
NCLEX Focus
Start with pregnancy exclusion and red-flag neurologic/endocrine cues before narrowing to less urgent causes.
- Confirm whether the pattern is primary versus secondary amenorrhea.
- Obtain focused menstrual and reproductive history, including prior cycle regularity and recent pattern changes.
- Screen for associated endocrine cues: hirsutism, hair loss, headache, galactorrhea, and visual changes.
- Identify lifestyle contributors such as weight loss, inadequate nutrition, high exercise load, or severe stress burden.
- Support ordered diagnostics based on suspected cause: beta-hCG, prolactin, FSH/LH/estrogen, thyroid panel, androgen studies (for example testosterone/DHEAS), and targeted imaging.
- In primary amenorrhea pathways, anticipate chromosomal/anatomic evaluation when indicated.
- Assess long-term hypoestrogen risk and bone-health status in prolonged amenorrhea.
Nursing Interventions
- Prioritize timely pregnancy testing and escalation of concerning findings (severe headache, visual symptoms, or progressive endocrine signs).
- Support etiology-directed treatment plans, including hormonal regulation strategies when prescribed.
- Reinforce medication teaching for targeted therapies such as dopamine-agonist pathways in hyperprolactinemia contexts.
- Coordinate multidisciplinary care for functional causes (nutrition, mental health, and exercise-specialist support) when eating disorder or overtraining patterns are present.
- Reinforce bone-health prevention in chronic amenorrhea: adequate calcium/vitamin D intake, weight-bearing activity guidance, and follow-up bone-density monitoring as ordered.
- Provide emotional support and stigma-reducing education, especially when fertility or body-image concerns are prominent.
Missed-Endocrine-Pathology Risk
Amenorrhea with headache, galactorrhea, or visual change may indicate pituitary pathology and requires prompt diagnostic escalation.
Pharmacology
| Drug Class | Examples | Key Nursing Considerations |
|---|---|---|
| cycle-regulation hormonal therapy | Combined oral contraceptives, progestin therapy | May induce withdrawal bleeding and regulate cycles in selected etiologies; monitor contraindications and adherence. |
| dopamine agonists | Bromocriptine, cabergoline | Used for hyperprolactinemia-related amenorrhea; monitor symptom response and adverse effects. |
| bone-protection adjuncts | Calcium/vitamin D and selected osteoporosis therapies | Consider when prolonged hypoestrogenism increases bone-loss risk. |
Clinical Judgment Application
Clinical Scenario
A client with previously regular menses reports no periods for four months, recent weight loss, frequent high-intensity exercise, and intermittent headaches with galactorrhea.
- Recognize Cues: Secondary amenorrhea with possible functional and endocrine contributors.
- Analyze Cues: Differential includes pregnancy, hypothalamic suppression, and hyperprolactinemia/pituitary causes.
- Prioritize Hypotheses: Immediate priority is pregnancy exclusion and endocrine red-flag workup.
- Generate Solutions: Coordinate labs/imaging and multidisciplinary support while initiating safety-focused teaching.
- Take Action: Implement ordered evaluation and reinforce nutrition/stress/exercise counseling.
- Evaluate Outcomes: Etiology is clarified, cycles improve or safely managed, and long-term bone risk is addressed.
Related Concepts
- functional-reproductive-disorders - Amenorrhea is a major menstrual-pattern disorder within functional reproductive care.
- causes-of-infertility - Ovulatory dysfunction and hypothalamic/pituitary causes of amenorrhea overlap infertility pathways.
- ovulation-induction-agents - Etiology-specific fertility treatment may be needed in amenorrhea-related anovulation.
- diagnosing-pregnancy - Pregnancy is a key presumptive cause to exclude early in secondary amenorrhea.
- abnormal-uterine-bleeding - Amenorrhea and AUB are complementary menstrual-pattern disorders requiring differential triage.
Self-Check
- What is the first diagnostic branch in secondary amenorrhea evaluation?
- Which symptom cluster suggests possible pituitary involvement?
- Why is bone-health monitoring important in chronic amenorrhea?